Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date

The quest for the right combination of bronchodilators with different mechanisms of action such as long-acting muscarinic antagonists and long-acting β-agonists in the management of stable moderate-to-severe chronic obstructive pulmonary disease (COPD) is a topic of intense research activity current...

Descripción completa

Detalles Bibliográficos
Autores principales: Moitra, Subhabrata, Bhome, Arvind B, Brashier, Bill B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396584/
https://www.ncbi.nlm.nih.gov/pubmed/25897208
http://dx.doi.org/10.2147/DDDT.S53150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396584/
https://www.ncbi.nlm.nih.gov/pubmed/25897208
http://dx.doi.org/10.2147/DDDT.S53150

Ejemplares similares